Prevention and / or therapeutic medicinal composition of atopic dermatitis containing IL-31 antagonist as an active ingredient

摘要

Problem to be solved: to provide a medical composition effective for prevention and / or treatment of atopic dermatitis, which can improve the QOL of patients.Solution: the preventive and / or therapeutic pharmaceutical composition of atopic dermatitis containing an IL-31 antagonist as an active ingredient, the IL-31 antagonist suffered from atopic dermatitis at 0.1 mg to 1000 mg / body / 2 weeks, 0.1 mg to 1000 mg / body / 4 weeks, or 0.1 mg to 1000 mg / body / 8 weeks Or a pharmaceutical composition that is repeatedly administered at an equal dose and at the same administration interval to an object of fear.No selection